Ernest Belmonte

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Imaging findings of hepatic storage diseases.

Imaging findings of hepatic storage diseases.

Journal: Radiologia

Published: October 30, 2024

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk.

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk.

Journal: BMC gastroenterology

Published: September 19, 2024

HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T Cells.

HBV Suppression by Nucleos(t)ide Analogues Reduces PD-1 Expression on Liver-Resident T Cells.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 26, 2024

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.

Risk of Treatment Failure and Death after Ablation in Hepatocellular Carcinoma Patients-A Multiparametric Prediction.

Journal: Cancers

Published: May 10, 2023

MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.

MRI Using Gadoxetic Acid in the Work-Up of Liver Nodules Not Conclusively Benign in Budd-Chiari Syndrome: A Prospective Long-Term Follow-Up.

Journal: Liver cancer

Published: December 09, 2022

Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.

Liver cancer risk after HCV cure in patients with advanced liver disease without non-characterized nodules.

Journal: Journal of hepatology

Published: May 30, 2021

Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.

Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: February 15, 2021

Joint position statement of the Societat Catalana de Digestologia and the Societat Catalana de Radiologia on gastroenterologist-led ultrasound in Catalonia.

Joint position statement of the Societat Catalana de Digestologia and the Societat Catalana de Radiologia on gastroenterologist-led ultrasound in Catalonia.

Journal: Gastroenterologia y hepatologia

Published: January 26, 2021

Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.

Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs.

Journal: United European gastroenterology journal

Published: January 12, 2021

Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].

Corrigendum to "Time association between hepatitis C therapy and hepatocellular carcinoma emergence in cirrhosis: Relevance of non-characterized nodules" [J Hepatol (2019) 874-884].

Journal: Journal of hepatology

Published: December 15, 2020

Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.

Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis.

Journal: Journal of hepatology

Published: May 23, 2020

Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.

Evaluation of LI-RADS 3 category by magnetic resonance in US-detected nodules ≤ 2 cm in cirrhotic patients.

Journal: European radiology

Published: May 05, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026